Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX5M6P
|
||||
| Drug Name |
6-(4-chlorobenzyl)-7-(2-cyclopentylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL523501
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H21ClN4
|
||||
| Canonical SMILES |
Clc1ccc(Cc2cc3cnc(nc3n2CCC4CCCC4)C#N)cc1
|
||||
| InChI |
InChI=1S/C21H21ClN4/c22-18-7-5-16(6-8-18)11-19-12-17-14-24-20(13-23)25-21(17)26(19)10-9-15-3-1-2-4-15/h5-8,12,14-15H,1-4,9-11H2
|
||||
| InChIKey |
MTVNDTARQDTHDY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.